Neuronox Botulinum Toxin [100iu]

This Botox-based medicine is indicated to temporarily improve the aesthetic appearance of expression lines, especially the glabellar ones (that is, those facial folds that appear between the eyebrows), which appear when you tend to frown often. The drug was tested on patients up to 65 years of age and it was noted that, in addition to improving aesthetics, mood was also improved. In fact, not undergoing trauma from surgery, the medicine works by smoothing the face, with a significant psychological impact on patients suffering from this problem.

It must be said that the Speywood units of this specific drug have been dosed only and exclusively for this preparation, therefore they are not interchangeable with those of other botulinum toxin-based preparations. Furthermore, it is advisable not to administer the product to children and young people under the age of 18, as safety and efficacy have not yet been demonstrated. Neuromox should only be prepared and administered by qualified personnel with proven treatment experience and equipped with the necessary equipment. Once reconstituted, the medicinal product should be used to treat only one patient during a single session. The doctor will observe and palpate the patient to look for the correct injection sites and proceed with treatment. Otherwise, there will be great risks as the botulinum toxin paralyzes the area into which it is injected. Think about what would happen if the needle ended up in a wrong blood vessel or nerve. It is not uncommon for an overdose to cause symptoms such as difficulty in breathing and swallowing: in the event of any adverse reaction, notify your doctor immediately.

The effectiveness of Neuronox is temporary and it has been shown that optimal results will be achieved for up to 4 months after injections. Obviously, everything is subjective, as in some patients it could last more than 5 months, or less. It all depends on the type of pathology to be treated, the initial conditions and whether the patient has a decrease in effect. In any case, a suspension period of not less than 3 months is required. In the event of treatment failure or diminished effect after repeated courses of therapy, alternative therapies should be considered. Usually, doctors start with a low dose and then go up, so that the patient can accustom the body to the presence of botulinum toxin.

Patients should not bend, push injection sites or lie down for 4 hours after injection. The patient should not be physically active for 90 minutes. The spread of Botulinum toxin in the eyelid can paralyze upper levator muscle and cause a transient passage.

Do not inject if the patient has demonstrated hypersensitivity to the active substance or to any of the listed excipients; in the presence of infections at the sites proposed for inoculation; in the presence of myasthenia gravis, Eaton Lambert syndrome or amyotrophic lateral sclerosis.